Article
Modified vaccinia virus Ankara as vaccine vectors in human and veterinary medicine
Registro en:
QUINAN, Bárbara Resende et al. Modified vaccinia virus Ankara as vaccine vectors in human and veterinary medicine. Future Virology. Vol. 9, No. 2, p. 173-187, 2014
1746-0794
10.2217/fvl.13.129 10.2217/fvl.13.129
Autor
Quinan, Bárbara Resende
Daian, Danielle Soares de Oliveira
Coelho, Fabiana Magalhães
Fonseca, Flávio Guimarães da
Resumen
Disease prevention through vaccination is one of the most important achievements of medicine. Today, we have a substantial number of vaccines against a variety of pathogens. In this context, poxviruses and vaccinology are closely related, as the birth of modern vaccinology was marked by the use of poxviruses as immunogens and so was the eradication of smallpox, one of the world's most feared diseases ever. Nowadays, poxviruses continue to notoriously contribute to vaccinology since their use as vaccine vectors has become popular and widespread. One of the most promising vectors is the modified vaccinia ankara. In this review we provide an overview of the contribution of poxvirus to vaccine immunology, particularly focusing on modified vaccinia ankara-based vaccines developed to date.